Chugai Pharmaceutical Co Ltd (OTCPK:CHGCY)
$ 22.58 0.57 (2.59%) Market Cap: 74.31 Bil Enterprise Value: 69.03 Bil PE Ratio: 28.55 PB Ratio: 6.51 GF Score: 85/100
Back to the Transcripts List

Chugai Pharmaceutical Co Ltd Information Meeting on ENSPRYNG Subcutaneous Injection Transcript

Sep 14, 2020 / NTS GMT
Release Date Price: $22.09 (-1.82%)
Katsuhiro Hara;ENSPRYNG Lifecycle Leader

Welcome, everyone. I am Katsuhiro Hara, ENSPRYNG Lifecycle Leader at Chugai Pharmaceutical Company Limited. I will give you the product overview of ENSPRYNG subcutaneous injection 120-milligram syringe.

Please turn to Slide 2. Therapeutic classification is pH-dependent binding humanized anti-interleukin-6 receptor, IL-6R, monoclonal antibody. The name of the product is ENSPRYNG subcutaneous injection 120-milligram syringe. A generic name is satralizumab, a genetic recombination. The packaging is, as shown on the slide, with 1 milliliter syringe placed in the box. The syringe is a preferred one as the liquid drug is in the syringe in advance and can be taken out and immediately be injected subcutaneously. Moreover, it is equipped with a system to prevent needle sticks called needle safety device, where after injection, the needle retracts into the barrel to ensure safety.

Please turn to Slide 3. This slide shows the involvement of IL-6 in the pathogenesis of neuromyelitis spectrum disorders, or NMOSD. As Dr. Fujihara will explain in more

Already have an account? Log in
Get the full story
Start 7-Day Free Trial
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.